Delivery Order SPE2DB22D2108-SPE2DB25FU4RM

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Vyvanse capsules (40mg) to the Defense Logistics Agency (DLA), a defense agency. The $34,466.34 firm-fixed-price delivery order contract has a period of performance through May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This federal contract award is for the delivery of Vyvanse 40 mg capsules (100-count bottles) to the Defense Logistics Agency (DLA), a defense agency. The $1,337.70 firm-fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of February 27, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $1,511.12. It is a firm fixed-price delivery order contract with a performance period extending through May 7, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 24, 2025 for a ceiling value of $4,906.88. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,337.70 and is a firm fixed-price delivery order with a completion date of February 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
The federal contract award is for the delivery of Vyvanse capsules, 30mg, to the Defense Logistics Agency (DLA). The $16,721.57 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,563.94 and a completion date of May 15, 2024. It is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of Vyvanse 40 mg capsules, a prescription medication, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $2,840.10 and an ultimate completion date of October 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This federal contract award is for the delivery of Vyvanse (lisdexamfetamine dimesylate) 40 mg capsules in quantities of 100 per bottle. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This is a firm-fixed-price delivery order with a ceiling value of $1,598.89 and an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is for the delivery of Vyvanse capsules (30mg) to the Defense Logistics Agency (DLA), which is a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $4,465.39 and is a Firm Fixed Price Delivery Order with an ultimate completion date of January 17, 2023. The contract was awarded on January 16, 2023 and does not have...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU4RM
    Delivery Order

The federal contract award is for the delivery of Vyvanse 40 mg capsules, with a ceiling value of $4,559.56. The contract was awarded on June 4, 2025, with a completion date of June 5, 2025. The contract is a delivery order, with a firm fixed price, and was awarded by the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 10:03 AM